» Articles » PMID: 35324692

Selection, Characterization, and Optimization of DNA Aptamers Against Challenging Marine Biotoxin Gymnodimine-A for Biosensing Application

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2022 Mar 24
PMID 35324692
Authors
Affiliations
Soon will be listed here.
Abstract

Gymnodimines (GYMs), belonging to cyclic imines (CIs), are characterized as fast-acting toxins, and may pose potential risks to human health and the aquaculture industry through the contamination of sea food. The existing detection methods of GYMs have certain defects in practice, such as ethical problems or the requirement of complicated equipment. As novel molecular recognition elements, aptamers have been applied in many areas, including the detection of marine biotoxins. However, GYMs are liposoluble molecules with low molecular weight and limited numbers of chemical groups, which are considered as "challenging" targets for aptamers selection. In this study, Capture-SELEX was used as the main strategy in screening aptamers targeting gymnodimine-A (GYM-A), and an aptamer named G48nop, with the highest value of 95.30 nM, was successfully obtained by screening and optimization. G48nop showed high specificity towards GYM-A. Based on this, a novel aptasensor based on biolayer interferometry (BLI) technology was established in detecting GYM-A. This aptasensor showed a detection range from 55 to 1400 nM (linear range from 55 to 875 nM) and a limit of detection (LOD) of 6.21 nM. Spiking experiments in real samples indicated the recovery rate of this aptasensor, ranging from 96.65% to 109.67%. This is the first study to report an aptamer with high affinity and specificity for the challenging marine biotoxin GYM-A, and the new established aptasensor may be used as a reliable and efficient tool for the detection and monitoring of GYMs in the future.

Citing Articles

Perspectives in Aptasensor-Based Portable Detection for Biotoxins.

Li C, Zhu Z, Yao J, Chen Z, Huang Y Molecules. 2024; 29(20).

PMID: 39459259 PMC: 11510259. DOI: 10.3390/molecules29204891.


The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.

Gezehagn Kussia G, Tessema T J Immunol Res. 2024; 2024:1804038.

PMID: 39156005 PMC: 11329312. DOI: 10.1155/2024/1804038.


Capture-SELEX: Selection Strategy, Aptamer Identification, and Biosensing Application.

Lam S, Lau H, Kwok C Biosensors (Basel). 2022; 12(12).

PMID: 36551109 PMC: 9776347. DOI: 10.3390/bios12121142.


Programmed Aptamer Screening, Characterization, and Rapid Detection for α-Conotoxin MI.

Guo H, Deng B, Zhao L, Gao Y, Zhang X, Yang C Toxins (Basel). 2022; 14(10).

PMID: 36287974 PMC: 9606946. DOI: 10.3390/toxins14100706.

References
1.
He F, Liang L, Zhou S, Xie W, He S, Wang Y . Label-Free Sensitive Detection of Microcystin-LR via Aptamer-Conjugated Gold Nanoparticles Based on Solid-State Nanopores. Langmuir. 2018; 34(49):14825-14833. DOI: 10.1021/acs.langmuir.8b00945. View

2.
Concepcion J, Witte K, Wartchow C, Choo S, Yao D, Persson H . Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High Throughput Screen. 2009; 12(8):791-800. DOI: 10.2174/138620709789104915. View

3.
Liu Y, Yu R, Kong F, Li C, Dai L, Chen Z . Lipophilic marine toxins discovered in the Bohai Sea using high performance liquid chromatography coupled with tandem mass spectrometry. Chemosphere. 2017; 183:380-388. DOI: 10.1016/j.chemosphere.2017.05.073. View

4.
Mufhandu H, Gray E, Madiga M, Tumba N, Alexandre K, Khoza T . UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C. J Virol. 2012; 86(9):4989-99. PMC: 3347371. DOI: 10.1128/JVI.06893-11. View

5.
Ellington A, Szostak J . In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346(6287):818-22. DOI: 10.1038/346818a0. View